Table 1 The main results of MR analysis between COVID 19 traits and migraine.

From: Brain structures as potential mediators of the causal effect of COVID 19 on migraine risk

Exposure

Outcome

nSNPs

OR (95% CI)

P value

PFDR

Power

GSMR

bxy_pval

OR (95% CI)

COVID 19 infection

Migraine

34

1.2502

(1.0592, 1.4756)

0.0083

0.0249

0.93

0.0103

1.25

(1.05, 1.47)

MA

27

1.4956

(1.1087, 2.0175)

0.0084

0.0168

0.98

0.0115

1.49

(1.09, 2.03)

COVID 19 hospitalization

Migraine

74

1.0689

(1.0136, 1.1271)

0.0138

0.0166

0.83

0.0143

1.06

(1.01, 1.12)

MA

73

1.0919

(1.0134, 1.1764)

0.0208

0.0208

0.73

0.0205

1.09

(1.01, 1.18)

COVID 19 severity

Migraine

46

1.0644

(1.0171, 1.1139)

0.0072

0.0432

0.88

0.0074

1.06

(1.02, 1.11)

MA

56

1.0844

(1.0197, 1.1533

0.0098

0.0147

0.87

0.0075

1.08

(1.02, 1.14)

migraine

COVID 19 infection

29

1.0056

(0.9733, 1.0391)

0.7359

1.1039

0.07

0.7444

1.01

(0.97, 1.04)

COVID 19 hospitalization

29

0.9946

(0.9242, 1.0703)

0.8851

0.8851

0.05

0.8645

0.99

(0.93, 1.07)

COVID 19 severity

30

0.9869

(0.8815, 1.1048)

0.8183

0.9819

0.06

0.8185

0.99

(0.89, 1.10)

MA

COVID 19 infection

10

0.9866

(0.9397, 1.0358)

0.5858

1.1716

0.13

0.5353

0.99

(0.95, 1.03)

COVID 19 hospitalization

10

1.0469

(0.9553, 1.1473)

0.3266

0.9798

0.32

0.3617

1.04

(0.95, 1.14)

COVID 19 severity

5

1.1862

(0.9769, 1.4403)

0.0846

0.5076

0.73

0.1027

1.18

(0.97, 1.44)

  1. CI, confidence interval; FDR: false discovery rate; GSMR, Generalized Summary-data-based Mendelian Randomization; IVW, Inverse Variance Weighted; MA, migraine with aura; OR, odds ratio; SNP, Single-Nucleotide Polymorphism.